CN Stock MarketDetailed Quotes

Hangzhou Bio-Sincerity Pharma-Tech (301096)

Watchlist
  • 63.68
  • -0.13-0.20%
Market Closed May 15 15:00 CST
6.96BMarket Cap-135.49P/E (TTM)

Hangzhou Bio-Sincerity Pharma-Tech (301096) Revenue Breakdown Overview

By Product

Currency:CNY
2025/FY
Stock NameRevenueRatio
研发技术成果转化247.31M36.48%
Clinical service136.17M20.09%
临床前药学研究121.89M17.98%
Commercial production89.28M13.17%
CDMO44.11M6.51%
Other32.98M4.86%
权益分成6.24M0.92%
View all

By Industry

Currency:CNY
2025/FY
Stock NameRevenueRatio
CRO行业544.59M80.33%
Commercial production89.28M13.17%
CDMO行业44.11M6.51%

By Country/Region

Currency:CNY
2025/FY
Stock NameRevenueRatio
Territory677.54M99.93%
Overseas446.33K0.07%

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

Market Insights
Middle East conflict spreads to the stock market! How should investors respond?
According to Axios, on Sunday local time, Trump rejected Iran's latest ceasefire proposal, prompting a sharp response from Iran: no one woul Show More